Lymphocyte-to-monocyte ratio is a valuable marker to predict prostate cancer in patients with prostate specific antigen between 4 and 10 ng/dl.
- Published in:
- Archives of Italian Urology & Andrology / Archivio Italiano di Urologia Andrologia, 2018, v. 90, n. 4, p. 270, doi. 10.4081/aiua.2018.4.270
- By:
- Publication type:
- Article